PMC:1283364 / 2923-3208 JSONTXT

Annnotations TAB JSON ListView MergeView

    craft-sa-dev

    {"project":"craft-sa-dev","denotations":[{"id":"T818","span":{"begin":2,"end":8},"obj":"VB"},{"id":"T836","span":{"begin":9,"end":11},"obj":"CC"},{"id":"T837","span":{"begin":12,"end":19},"obj":"VB"},{"id":"T838","span":{"begin":20,"end":23},"obj":"DT"},{"id":"T839","span":{"begin":24,"end":35},"obj":"NN"},{"id":"T840","span":{"begin":36,"end":40},"obj":"IN"},{"id":"T841","span":{"begin":41,"end":48},"obj":"NN"},{"id":"T842","span":{"begin":49,"end":51},"obj":"IN"},{"id":"T843","span":{"begin":52,"end":60},"obj":"NN"},{"id":"T844","span":{"begin":60,"end":61},"obj":"."},{"id":"T845","span":{"begin":61,"end":273},"obj":"sentence"},{"id":"T846","span":{"begin":62,"end":67},"obj":"JJ"},{"id":"T847","span":{"begin":68,"end":76},"obj":"NN"},{"id":"T848","span":{"begin":188,"end":197},"obj":"VBD"},{"id":"T849","span":{"begin":77,"end":81},"obj":"IN"},{"id":"T850","span":{"begin":82,"end":90},"obj":"JJ"},{"id":"T851","span":{"begin":91,"end":97},"obj":"NNS"},{"id":"T852","span":{"begin":98,"end":100},"obj":"IN"},{"id":"T853","span":{"begin":101,"end":109},"obj":"NN"},{"id":"T854","span":{"begin":110,"end":118},"obj":"VBN"},{"id":"T855","span":{"begin":109,"end":110},"obj":"HYPH"},{"id":"T856","span":{"begin":119,"end":128},"obj":"NN"},{"id":"T857","span":{"begin":128,"end":130},"obj":","},{"id":"T858","span":{"begin":130,"end":133},"obj":"CD"},{"id":"T859","span":{"begin":134,"end":136},"obj":"IN"},{"id":"T860","span":{"begin":137,"end":140},"obj":"DT"},{"id":"T861","span":{"begin":159,"end":169},"obj":"NNS"},{"id":"T862","span":{"begin":141,"end":146},"obj":"JJ"},{"id":"T863","span":{"begin":147,"end":149},"obj":"NN"},{"id":"T864","span":{"begin":150,"end":158},"obj":"VBG"},{"id":"T865","span":{"begin":149,"end":150},"obj":"HYPH"},{"id":"T866","span":{"begin":170,"end":176},"obj":"VBN"},{"id":"T867","span":{"begin":177,"end":179},"obj":"IN"},{"id":"T868","span":{"begin":180,"end":186},"obj":"NNS"},{"id":"T869","span":{"begin":186,"end":188},"obj":","},{"id":"T870","span":{"begin":198,"end":202},"obj":"IN"},{"id":"T871","span":{"begin":259,"end":261},"obj":"VB"},{"id":"T872","span":{"begin":203,"end":213},"obj":"NNS"},{"id":"T873","span":{"begin":214,"end":222},"obj":"VBN"},{"id":"T874","span":{"begin":223,"end":225},"obj":"TO"},{"id":"T875","span":{"begin":226,"end":232},"obj":"VB"},{"id":"T876","span":{"begin":233,"end":240},"obj":"NN"},{"id":"T877","span":{"begin":241,"end":247},"obj":"NN"},{"id":"T878","span":{"begin":248,"end":251},"obj":"MD"},{"id":"T879","span":{"begin":252,"end":258},"obj":"RB"},{"id":"T880","span":{"begin":262,"end":272},"obj":"JJ"},{"id":"T881","span":{"begin":272,"end":273},"obj":"."},{"id":"T883","span":{"begin":274,"end":282},"obj":"IN"}],"relations":[{"id":"R448","pred":"cc","subj":"T836","obj":"T818"},{"id":"R449","pred":"conj","subj":"T837","obj":"T818"},{"id":"R450","pred":"det","subj":"T838","obj":"T839"},{"id":"R451","pred":"dobj","subj":"T839","obj":"T837"},{"id":"R452","pred":"prep","subj":"T840","obj":"T839"},{"id":"R453","pred":"pobj","subj":"T841","obj":"T840"},{"id":"R454","pred":"prep","subj":"T842","obj":"T840"},{"id":"R455","pred":"pobj","subj":"T843","obj":"T842"},{"id":"R456","pred":"punct","subj":"T844","obj":"T818"},{"id":"R457","pred":"amod","subj":"T846","obj":"T847"},{"id":"R458","pred":"nsubj","subj":"T847","obj":"T848"},{"id":"R459","pred":"prep","subj":"T849","obj":"T847"},{"id":"R460","pred":"amod","subj":"T850","obj":"T851"},{"id":"R461","pred":"pobj","subj":"T851","obj":"T849"},{"id":"R462","pred":"prep","subj":"T852","obj":"T851"},{"id":"R463","pred":"npadvmod","subj":"T853","obj":"T854"},{"id":"R464","pred":"amod","subj":"T854","obj":"T856"},{"id":"R465","pred":"punct","subj":"T855","obj":"T854"},{"id":"R466","pred":"pobj","subj":"T856","obj":"T852"},{"id":"R467","pred":"punct","subj":"T857","obj":"T856"},{"id":"R468","pred":"appos","subj":"T858","obj":"T856"},{"id":"R469","pred":"prep","subj":"T859","obj":"T858"},{"id":"R470","pred":"det","subj":"T860","obj":"T861"},{"id":"R472","pred":"amod","subj":"T862","obj":"T861"},{"id":"R473","pred":"npadvmod","subj":"T863","obj":"T864"},{"id":"R474","pred":"amod","subj":"T864","obj":"T861"},{"id":"R475","pred":"punct","subj":"T865","obj":"T864"},{"id":"R476","pred":"acl","subj":"T866","obj":"T861"},{"id":"R477","pred":"prep","subj":"T867","obj":"T866"},{"id":"R478","pred":"pobj","subj":"T868","obj":"T867"},{"id":"R479","pred":"punct","subj":"T869","obj":"T848"},{"id":"R480","pred":"mark","subj":"T870","obj":"T871"},{"id":"R481","pred":"ccomp","subj":"T871","obj":"T848"},{"id":"R482","pred":"nsubj","subj":"T872","obj":"T871"},{"id":"R483","pred":"acl","subj":"T873","obj":"T872"},{"id":"R484","pred":"aux","subj":"T874","obj":"T875"},{"id":"R485","pred":"advcl","subj":"T875","obj":"T873"},{"id":"R486","pred":"compound","subj":"T876","obj":"T877"},{"id":"R487","pred":"dobj","subj":"T877","obj":"T875"},{"id":"R488","pred":"aux","subj":"T878","obj":"T871"},{"id":"R489","pred":"advmod","subj":"T879","obj":"T871"},{"id":"R490","pred":"acomp","subj":"T880","obj":"T871"},{"id":"R491","pred":"punct","subj":"T881","obj":"T848"},{"id":"R471","pred":"pobj","subj":"T861","obj":"T859"}],"text":"r arrest or reverse the progression from peptide to dementia.\nEarly evidence from clinical trials of antibody-mediated clearance, one of the first Aβ-lowering approaches tested in humans, suggested that treatments designed to reduce amyloid burden may indeed be beneficial. Although th"}

    craft-ca-core-ex-dev

    {"project":"craft-ca-core-ex-dev","denotations":[{"id":"T633","span":{"begin":41,"end":48},"obj":"CHEBI_SO_EXT:peptide_or_peptide_region"},{"id":"T634","span":{"begin":101,"end":109},"obj":"GO:0042571"},{"id":"T635","span":{"begin":147,"end":149},"obj":"CHEBI_PR_EXT:amyloid_beta"},{"id":"T636","span":{"begin":180,"end":186},"obj":"NCBITaxon:9606"},{"id":"T637","span":{"begin":233,"end":240},"obj":"CHEBI:60425"}],"text":"r arrest or reverse the progression from peptide to dementia.\nEarly evidence from clinical trials of antibody-mediated clearance, one of the first Aβ-lowering approaches tested in humans, suggested that treatments designed to reduce amyloid burden may indeed be beneficial. Although th"}

    craft-ca-core-dev

    {"project":"craft-ca-core-dev","denotations":[{"id":"T559","span":{"begin":101,"end":109},"obj":"GO:0042571"},{"id":"T560","span":{"begin":180,"end":186},"obj":"NCBITaxon:9606"},{"id":"T561","span":{"begin":233,"end":240},"obj":"CHEBI:60425"}],"text":"r arrest or reverse the progression from peptide to dementia.\nEarly evidence from clinical trials of antibody-mediated clearance, one of the first Aβ-lowering approaches tested in humans, suggested that treatments designed to reduce amyloid burden may indeed be beneficial. Although th"}